book a demo

-20th April 2016

Top UK NHS cancer centre chooses Mirada Medical’s technology to further improve confidence in radiotherapy patient care

Mirada Medical is proud and excited about the opportunity to work with the clinicians and physicists at The Christie hospital in Manchester, England, a World-renowned centre for complete cancer care. The Christie is the only UK hospital that will be treating cancer patients with proton therapy & MRI guided linear accelerators (LINAC), whilst benefiting from the latest advancements in diagnostics with PET/MRI, making it one of the most comprehensive cancer centres. With Mirada specialising in software to enable collaboration between departments and treatment methods, this is a natural relationship that will support fundamental changes in treatment protocols, reducing time to treatment whilst improving clinical confidence and efficacy.   “We have chosen Mirada as strategic partner to develop multimodality imaging solutions because of the quality of their software, allowing rapid translation of novel techniques into our clinic while also providing the possibility to efficiently integrate workflows for the different treatment techniques that are available at our site,” said Professor Marcel Van Herk, Chair in Radiotherapy Physics at the University of Manchester and The Christie NHS Foundation Trust. The Christie is joining many other famous institutes in the world that have chosen Mirada for their robust image fusion, adaptive radiotherapy and molecular imaging solutions. This is testimony to the company’s capabilities to support the next generation of pioneering radiotherapy and nuclear medicine departments. “We’re very pleased that one of the most respected cancer institutes in the UK, The Christie, has chosen Mirada image fusion technology to add to their state-of-the-art patient care.” said András Szentmiklóssy, Product Manager, Radiotherapy Solutions at Mirada Medical. “It’s exciting to be a preferred partner in a premier oncology workflow environment that includes proton therapy, PET/MRI imaging and MRI guided LINAC, all aimed at advancing the latest in precision radiotherapy and cancer care.” continues András Szentmiklóssy.

About Mirada Medical Ltd

Mirada Medical is a leading international brand in medical imaging. The company develops advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Mirada’s products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, Multidisciplinary meetings and elsewhere.

Mirada’s technologies and products continue to be developed by their team of specialists, engineers and world-renowned scientists at Mirada’s world headquarters in Oxford, England. For more information about Mirada Medical products visit http://www.mirada-medical.com